Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.

Suppr

超能文献

作者信息

Manna M, Nesci S, Andreani M, Tonucci P, Lucarelli G

机构信息

Divisione di Ematologia, Ospedale di Muraglia, U.S.L. 3, Pesaro, Italia.

出版信息

Bone Marrow Transplant. 1993;12 Suppl 1:70-3.

PMID:8104074

Abstract

摘要

相似文献

Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.

Bone Marrow Transplant. 1993;12 Suppl 1:70-3.

Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.骨髓移植后地中海贫血患者造血祖细胞的研究。

Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:291-5.

Bone marrow transplantation in thalassemia. The Cagliari team experience.

Bone Marrow Transplant. 1993;12 Suppl 1:45-6.

Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.外周血与骨髓作为重型Ⅰ级和Ⅱ级β地中海贫血患儿异基因移植造血干细胞来源的比较

Biol Blood Marrow Transplant. 2008 Mar;14(3):301-8. doi: 10.1016/j.bbmt.2007.12.491.

Bone marrow transplantation for children with thalassemia: two years' experience with low-dose busulfan, citoxan and GM-CSF.地中海贫血患儿的骨髓移植：低剂量白消安、环磷酰胺和粒细胞巨噬细胞集落刺激因子的两年经验

Bone Marrow Transplant. 1993;12 Suppl 1:51-3.

Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.使用白消安和环磷酰胺进行预处理化疗后，无关供体移植后的骨髓植入情况。

Bone Marrow Transplant. 1996 Apr;17(4):479-83.

Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.白消安和环磷酰胺预处理后异基因骨髓移植治疗慢性髓性白血病的结果

J Assoc Physicians India. 1999 Aug;47(8):770-3.

Murine and math models for the level of stable mixed chimerism to cure beta-thalassemia by nonmyeloablative bone marrow transplantation.通过非清髓性骨髓移植实现稳定混合嵌合水平以治愈β地中海贫血的小鼠和数学模型。

Ann N Y Acad Sci. 2005;1054:423-8. doi: 10.1196/annals.1345.061.

Bone Marrow Transplant. 1996 May;17(5):685-9.

Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.在伊朗南部设拉子，采用“短疗程”抗胸腺细胞球蛋白疗法对重型地中海贫血患者进行骨髓移植。

Transplant Proc. 2005 Dec;37(10):4477-81. doi: 10.1016/j.transproceed.2005.10.014.

引用本文的文献

Unmanipulated Stem Cell Boost for Mixed Chimerism in Transfusion Dependent Thalassemia.未经处理的干细胞增强输血依赖型地中海贫血中的混合嵌合状态。

Indian J Hematol Blood Transfus. 2021 Jul;37(3):458-462. doi: 10.1007/s12288-020-01347-z. Epub 2020 Sep 3.

Long--Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation.两名Ⅲ型β地中海贫血患者非清髓性干细胞移植后的长期无病生存

Int J Hematol Oncol Stem Cell Res. 2020 Apr 1;14(2):118-122.

Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.诱导多能干细胞对β地中海贫血嵌合小鼠的治疗作用。

Haematologica. 2014 Aug;99(8):1304-11. doi: 10.3324/haematol.2013.087916. Epub 2014 May 9.

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.在因重型地中海贫血或镰状细胞病而接受骨髓移植后长期、持续存在造血混合嵌合体的患者中，存在定量不同的红细胞/有核细胞嵌合体。

Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7.

Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.地中海贫血患者骨髓移植后混合嵌合体与排斥反应之间的关系

Blood Transfus. 2008 Jul;6(3):143-9. doi: 10.2450/2008.0051-07.

Impaired liver function tests in patients treated with antithymocyte globulin: implication for liver transplantation.

Med Oncol. 1997 Sep-Dec;14(3-4):125-9. doi: 10.1007/BF02989638.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验